Archives for March 21, 2006

← 2006

New brain disorder tools results in new drugs

By  Wai Lang Chu

Researchers have constructed a model of an axon, which they have used to reproduce a change in the axon's shape that is characteristic of neurodegenerative disorders. The model provides a new road to discovering new kinds of drugs for the treatment of...

Tripos announces Abbott informatics agreement

By  Wai Lang Chu

Drug discovery outfit, Tripos, has announced details of a collaboration with Abbott, which is to concentrate on chemical design and synthesis in a deal that mirrors, those announced earlier in Q1 with Genzyme, GSK Research and Development and...

Pharmaceutical Institute offers research of choice

By staff reporter

The Pharmaceutical Institute, provider of specialised knowledge for the pharma industry, is now providing custom research services to cater for those with complex research needs.

Shimadzu introduces latest ICP spectrometer

By  Wai Lang Chu

Shimadzu have introduced its latest emission spectrometer, which has been designed for use in pharmaceutical research and development whilst reducing reduced running-costs and high sensitivity and low contamination.

Ventiv goes on a shopping spree

By Kirsty Barnes

Ventiv Health has spent the last month buying up companies. After buying Aheris in February, the company has since agreed to acquire US clinical services provider Synergos, as well as Canadian healthcare marketing and communications agency, Jeffrey...

NicOx and Merck sign antihypertensive agreement

By  Wai Lang Chu

NicOx and Merck have signed an agreement to collaborate on the development of new antihypertensive drugs. The agreement follows the successful completion of the companies' research collaboration, which has generated promising results.